Chad Messer
Stock Analyst at Lake Street
(0.45)
# 3,993
Out of 4,876 analysts
24
Total ratings
29.17%
Success rate
-26.92%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Chad Messer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BOLT Bolt Biotherapeutics | Initiates: Buy | $80 | $5.76 | +1,288.89% | 1 | May 20, 2025 | |
| LTRN Lantern Pharma | Initiates: Buy | $25 | $3.14 | +696.18% | 1 | Apr 2, 2025 | |
| IMNM Immunome | Initiates: Buy | $23 | $8.77 | +162.26% | 1 | Apr 2, 2025 | |
| OSTX OS Therapies | Initiates: Buy | $19 | $1.81 | +949.72% | 1 | Apr 2, 2025 | |
| ESPR Esperion Therapeutics | Maintains: Strong Buy | $134 → $114 | $1.02 | +11,076.47% | 3 | Aug 3, 2021 | |
| CELC Celcuity | Initiates: Buy | $50 | $11.98 | +317.54% | 1 | Jul 27, 2021 | |
| CYTK Cytokinetics | Maintains: Buy | $33 → $48 | $33.91 | +41.55% | 2 | Jul 19, 2021 | |
| EXEL Exelixis | Maintains: Buy | $33 → $30 | $43.09 | -30.38% | 3 | Jun 28, 2021 | |
| RNA Avidity Biosciences | Initiates: Buy | $50 | $29.83 | +67.62% | 1 | Jun 17, 2021 | |
| CRMD CorMedix | Maintains: Buy | $31 → $29 | $14.96 | +93.85% | 2 | May 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $2.80 | +257.14% | 1 | Apr 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $95 → $86 | $39.78 | +116.19% | 2 | Mar 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $2.02 | +3,612.87% | 1 | Mar 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $44 | $11.83 | +271.94% | 2 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $182 → $166 | $17.23 | +863.44% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $18 | $3.74 | +381.28% | 1 | May 5, 2020 |
Bolt Biotherapeutics
May 20, 2025
Initiates: Buy
Price Target: $80
Current: $5.76
Upside: +1,288.89%
Lantern Pharma
Apr 2, 2025
Initiates: Buy
Price Target: $25
Current: $3.14
Upside: +696.18%
Immunome
Apr 2, 2025
Initiates: Buy
Price Target: $23
Current: $8.77
Upside: +162.26%
OS Therapies
Apr 2, 2025
Initiates: Buy
Price Target: $19
Current: $1.81
Upside: +949.72%
Esperion Therapeutics
Aug 3, 2021
Maintains: Strong Buy
Price Target: $134 → $114
Current: $1.02
Upside: +11,076.47%
Celcuity
Jul 27, 2021
Initiates: Buy
Price Target: $50
Current: $11.98
Upside: +317.54%
Cytokinetics
Jul 19, 2021
Maintains: Buy
Price Target: $33 → $48
Current: $33.91
Upside: +41.55%
Exelixis
Jun 28, 2021
Maintains: Buy
Price Target: $33 → $30
Current: $43.09
Upside: -30.38%
Avidity Biosciences
Jun 17, 2021
Initiates: Buy
Price Target: $50
Current: $29.83
Upside: +67.62%
CorMedix
May 14, 2021
Maintains: Buy
Price Target: $31 → $29
Current: $14.96
Upside: +93.85%
Apr 5, 2021
Initiates: Buy
Price Target: $10
Current: $2.80
Upside: +257.14%
Mar 23, 2021
Maintains: Buy
Price Target: $95 → $86
Current: $39.78
Upside: +116.19%
Mar 15, 2021
Initiates: Buy
Price Target: $75
Current: $2.02
Upside: +3,612.87%
Jan 8, 2021
Maintains: Buy
Price Target: $35 → $44
Current: $11.83
Upside: +271.94%
Jan 8, 2021
Maintains: Buy
Price Target: $182 → $166
Current: $17.23
Upside: +863.44%
May 5, 2020
Maintains: Buy
Price Target: $15 → $18
Current: $3.74
Upside: +381.28%